Biofusion Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 42.71 Cr
- Revenue Growth 40.67%
- Profit Growth 2670.46%
- Ebitda -71.61%
- Net Worth 2642.46%
- Total Assets -64.51%
About Biofusion Therapeutics
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73100KA2021PLC145487
- Company No.
145487
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2021
- Date of AGM
11 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Biofusion Therapeutics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiran Shaw  | Director | 18-Mar-2021 | Current |
| Karaikal Krishnan | Director | 27-Jul-2022 | Current |
| Siddharth Mittal | Director | 18-Mar-2021 | Current |
Financial Performance of Biofusion Therapeutics.
Biofusion Therapeutics Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.67% increase. The company also saw a substantial improvement in profitability, with a 2670.46% increase in profit. The company's net worth Soared by an impressive increase of 2642.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biofusion Therapeutics?
In 2023, Biofusion Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Science Gallery BengaluruKiran Shaw is a mutual person
Mazumdar Shaw Medical FoundationKiran Shaw is a mutual person
Immuneel Therapeutics Private LimitedKiran Shaw is a mutual person
Trent LimitedKiran Shaw is a mutual person
Csep Research FoundationKiran Shaw is a mutual person
Biocon AcademySiddharth Mittal and Kiran Shaw are mutual person
Charges (Loans)
₹0
₹427.14 M
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 42.71 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Apr 2022 | Citi Bank N.A. | ₹42.71 Cr | Satisfied |
How Many Employees Work at Biofusion Therapeutics?
Biofusion Therapeutics has a workforce of 3 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biofusion Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biofusion Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
